MoneyWorks4Me

Alkem Laboratories informs about conference call

18 May 2017 Evaluate

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alkem Laboratories has informed that a conference call to discuss the Q4FY17 & FY17 financial results and business updates will be held on Friday, 26th May, 2017 at 5.30 P.M.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5347.00 -6.00 (-0.11%)
25-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1917.00
Dr. Reddys Labs. 1191.00
Cipla 1420.00
Lupin 2175.00
Zydus Lifesciences 1130.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: